{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:58:44Z","timestamp":1790110724970,"version":"4.0.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/cmr.0b013e32831993f3","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T13:57:19Z","timestamp":1242914239000},"page":"135-141","source":"Crossref","is-referenced-by-count":17,"title":["Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas"],"prefix":"10.1097","volume":"19","author":[{"given":"Bianca Costa","family":"Soares de S\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Lissae","family":"Fugimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina de C\u00e1ssia","family":"Braga Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pedreira","family":"Duprat Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rog\u00e9rio Izar","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Landman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(02)09779-9","article-title":"Incidence of and survival from malignant melanoma in Scotland: an epidemiological study","volume":"360","author":"Mackie","year":"2002","journal-title":"Lancet"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1023643219686","article-title":"Sentinel network of pathologists; sentinel network of dermatologists for melanoma: epidemiological survey of melanoma in the Auvergne region (France): is there an increased incidence in Auvergne?","volume":"18","author":"Gerbaud","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1365-2133.2003.05554.x","article-title":"Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer)","volume":"149","author":"Katalinic","year":"2003","journal-title":"Br J Dermatol"},{"key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0959-8049(03)00320-4","article-title":"Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient?","volume":"39","author":"De Vries","year":"2003","journal-title":"Eur J Cancer"},{"key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(05)17951-3","article-title":"Cutaneous melanoma","volume":"365","author":"Thompson","year":"2005","journal-title":"Lancet"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1365-4362.2002.01601.x","article-title":"Cell cycle in sporadic melanoma","volume":"41","author":"Czajkowski","year":"2002","journal-title":"Int J Dermatol"},{"key":"R7-2-20210129","first-page":"5475","article-title":"The p16-cyclin D\/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis","volume":"56","author":"Bartkova","year":"1996","journal-title":"Cancer Res"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/bjc.1996.181","article-title":"Involvement of the pRb\/p16\/Cdk4\/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas","volume":"73","author":"Maelandsmo","year":"1996","journal-title":"Br J Cancer"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00008469-200304000-00002","article-title":"p53-related pathways and the molecular pathogenesis of melanoma","volume":"12","author":"Hussein","year":"2003","journal-title":"Eur J Cancer Prev"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1254\/jphs.94.166","article-title":"p53-mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells","volume":"94","author":"Wu","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat Med"},{"key":"R12-2-20210129","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00008390-200402000-00006","article-title":"Validation of tissue microarray for the immunohistochemical profiling of melanoma","volume":"14","author":"Pacifico","year":"2004","journal-title":"Melanoma Res"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1158\/1078-0432.CCR-05-2504","article-title":"Pathology of melanoma","volume":"12","author":"Elder","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.sap.0000171429.19320.ce","article-title":"Identification of P-cadherin in primary melanoma using a tissue microarrayer: prognostic implications in a patient cohort with long-term follow up","volume":"55","author":"Pacifico","year":"2005","journal-title":"Ann Plast Surg"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00008390-200510000-00012","article-title":"nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up","volume":"15","author":"Pacifico","year":"2005","journal-title":"Melanoma Res"},{"key":"R18-2-20210129","article-title":"Estimative\/2008: Brazil cancer incidence","year":"2007"},{"key":"R19-2-20210129","first-page":"2713","article-title":"Loss of expression of the p16\/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression","volume":"55","author":"Reed","year":"1995","journal-title":"Cancer Res"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9440(10)63110-0","article-title":"Progression in cutaneous malignant melanoma is associated with distinct expression profiles a tissue microarray-based study","volume":"164","author":"Alonso","year":"2004","journal-title":"Am J Pathol"},{"key":"R21-2-20210129","first-page":"331","article-title":"Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells","volume":"24","author":"Zhang","year":"2004","journal-title":"Int J Oncol"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnci\/95.10.723","article-title":"p16\/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression","volume":"95","author":"Sviderskaya","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1067\/mjd.2000.104687","article-title":"Melanoma genetics: an update with focus on the CDKN2A (p16)\/ARF tumor suppressors","volume":"42","author":"Piepkorn","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R24-2-20210129","first-page":"3614","article-title":"Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma","volume":"6","author":"Florenes","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2004.07.033","article-title":"Expression profiles of Id1 and p16 proteins in all-trans-retinoic acid-induced apoptosis and cell cycle re-distribution in melanoma","volume":"217","author":"Zhang","year":"2005","journal-title":"Cancer Lett"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1210\/en.2004-0959","article-title":"Minireview: cyclin D1: normal and abnormal functions","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccr.2007.03.009","article-title":"Rewiring ERK-JNK signaling pathways in melanoma","volume":"11","author":"Lopez-Bergami","year":"2007","journal-title":"Cancer cell"},{"key":"R28-2-20210129","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determinants of BRAF mutations in primary melanomas","volume":"95","author":"Maldonado","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R29-2-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0560.2006.00700.x","article-title":"Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings","volume":"34","author":"Tchernev","year":"2007","journal-title":"J Cutan Pathol"},{"key":"R30-2-20210129","first-page":"1813","article-title":"Cyclin kinase inhibitor p21WAF1\/CIP1 in malignant melanoma: reduced expression in metastatic lesions","volume":"149","author":"Maelandsmo","year":"1996","journal-title":"Am J Pathol"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008390-200906000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:46:40Z","timestamp":1618033600000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-200906000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e32831993f3","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}